Sign Up to like & get
recommendations!
1
Published in 2022 at "Endocrine journal"
DOI: 10.1507/endocrj.ej21-0696
Abstract: The insufficient activity of insulin and the hyperactivity of glucagon are responsible for glucose intolerance in patients with type 2 diabetes. Whereas sodium-glucose cotransporter-2 (SGLT2) inhibitors improve blood glucose levels in patients with type 2…
read more here.
Keywords:
patients type;
effects luseogliflozin;
secretion;
luseogliflozin secretion ... See more keywords